Advertisement

Hepatitis C Virus Nonstructural Region 5A Protein: A Potent Transcriptional Activator

  • Naoya Kato
  • Keng-Hsin Lan
  • Suzane Kioko Ono-Nita
  • Hideo Yoshida
  • Yasushi Shiratori
  • Masao Omata
Conference paper

Abstract

Hepatitis C virus (HCV) is a positive-stranded RNA virus of genomic size of approximately 10 kilobases which is distantly related to the flaviviruses and the pestiviruses of the flavivirus family [1,2]. HCV RNA is detected in the serum of patients with non-A, non-B hepatitis using the assay method of reverse transcription followed by the polymerase chain reaction (RT-PCR). RT-PCR analysis of HCV RNA shows that the majority of anti-HCV-positive patients with chronic liver disease are HCV carriers [3]. The HCV genome contains a large open reading frame encoding a polyprotein precursor of 3010–3033 amino acids and an untranslated region (UTR) at the 5′ and 3′ ends of the genome. The putative organization of the HCV genome includes the 5′ UTR, 3 structural proteins, 7 nonstructural (NS) proteins, and the 3′ UTR, in order from the 5′ end [4]. One of the NS proteins, NS5A protein, is a serine phosphoprotein with two isoforms, p56 and p58 (the hyperphosphorylated form of p56) [5]. Clinically, a close association was demonstrated between mutations in the NS5A gene of HCV-lb and the response to interferon-α in patients with chronic active hepatitis [6,7]. Recently, the NS5A protein was shown to bind interferon-induced antiviral protein, PKR (double-stranded RNA-dependent protein kinase), and inhibit its kinase activity [8]. However, the function of the NS5A protein is still not fully understood. The NS5A protein was found to possess a nuclear localization-like signal sequence and to be localized in the nuclear periplasmic membrane fraction, so it seems that it may have some function related to transcription or translation [9].

Keywords

Huh7 Cell Chronic Active Hepatitis Galactosidase Activity NS5A Protein Interferon Sensitivity Determine Region 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362PubMedCrossRefGoogle Scholar
  2. 2.
    Miller RH, Purcell RH (1990) Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 87:2057–2061PubMedCrossRefGoogle Scholar
  3. 3.
    Kato N, Yokosuka O, Omata M, Hosoda K, Ohto M (1990) Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest 86:1764–1767PubMedCrossRefGoogle Scholar
  4. 4.
    Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coito D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M (1991) Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451–2455PubMedCrossRefGoogle Scholar
  5. 5.
    Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K, Shimotohno K (1994) Production of two phosphoproteins from the NS5A region of the hepatitis C virus genome. Biophys Biochem Res Commun 205:320–326CrossRefGoogle Scholar
  6. 6.
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C (1995) Comparison of full-length sequences of interferonsensitive and resistant hepatitis C virus lb: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224–230PubMedCrossRefGoogle Scholar
  7. 7.
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996) Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus lb infection. N Engl J Med 334:77–81PubMedCrossRefGoogle Scholar
  8. 8.
    Gale MJ Jr, Korth MJ, Tang NM, Tan S-L, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG (1997) Evidence that hepatitis C virus resistant to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217–227PubMedCrossRefGoogle Scholar
  9. 9.
    Tanji Y, Kaneko T, Satoh S, Shimotohno K (1995) Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69:3980–3986PubMedGoogle Scholar
  10. 10.
    Kato N, Lan K-H, Ono-Nita SK, Shiratori Y, Omata M (1997) Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 71:8856–8859PubMedGoogle Scholar
  11. 11.
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992) Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673–679PubMedCrossRefGoogle Scholar
  12. 12.
    Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M (1993) Detection of hepatitis C virus RNA in acute non-A, non-B hepatitis as an early diagnostic tool. Biochem Biophys Res Commun 192:800–807PubMedCrossRefGoogle Scholar
  13. 13.
    Togo G, Toda N, Kanai F, Kato N, Shiratori Y, Kishi K, Imazeki F, Makuuchi M, Omata M (1996) A transforming growth factor ß type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res 56:5620–5623PubMedGoogle Scholar
  14. 14.
    Becker DM, Guarente L (1991) High-efficiency transformation of yeast by electroporation. In: Guthrie C, Fink GR (eds) Methods in enzymology, vol. 194, Guide to yeast genetics and molecular biology. Academic, San Diego, pp 182–187Google Scholar
  15. 15.
    Sambrook J, Fritsch EF, Maniatis T (1989) Expression of cloned genes in cultured mammalian cells. In: Nolan C (ed) Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Plainview, pp 16. 1–16.Google Scholar
  16. 16.
    Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42:3858–3863PubMedGoogle Scholar
  17. 17.
    Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring HarborGoogle Scholar
  18. 18.
    Sambrook J, Fritsch EF, Maniatis T (1989) Detection and analysis of proteins expressed from cloned genes. In: Nolan C (ed) Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Plainview, pp 18.1–18.88Google Scholar
  19. 19.
    Courey AJ, Tjian R (1988) Analysis of Spl in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887–898PubMedCrossRefGoogle Scholar
  20. 20.
    Ma J, Ptashne M (1987) A new class of yeast transcriptional activators. Cell 51:113–119PubMedCrossRefGoogle Scholar
  21. 21.
    Mermod N, O’Neill EA, Kelly TJ, Tjian R (1989) The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell 58:741–753PubMedCrossRefGoogle Scholar
  22. 22.
    Campbell ME, Palfreyman JW, Preston CM (1984) Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. J Mol Biol 180:1–19PubMedCrossRefGoogle Scholar
  23. 23.
    Hope IA, Struhl K (1986) Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell 46:885–894PubMedCrossRefGoogle Scholar
  24. 24.
    Ma J, Ptashne M (1987) Deletion analysis of GAL4 defines two transcriptional activating segments. Cell 48:847–853PubMedCrossRefGoogle Scholar
  25. 25.
    Mitchell PJ, Tjian R (1989) Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371–378PubMedCrossRefGoogle Scholar
  26. 26.
    Asabe S, Tanji Y, Satoh S, Kaneko T, Kimura K, Shimotohno K (1997) The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. J Virol 71:790–796PubMedGoogle Scholar
  27. 27.
    Radtke F, Georgiev O, Muller H-P, Brugnera E, Schaffner W (1995) Functional domains of the heavy metal-responsive transcription regulator MTF-1. Nucleic Acids Res 23:2277–2286PubMedCrossRefGoogle Scholar
  28. 28.
    Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee AS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 344:362–364CrossRefGoogle Scholar
  29. 29.
    Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15:948–963PubMedCrossRefGoogle Scholar
  30. 30.
    Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q-L, Houghton M, Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547–6549PubMedCrossRefGoogle Scholar
  31. 31.
    Seiki M, Inoue J, Takeda T, Yoshida M (1986) Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J 5:561–565PubMedGoogle Scholar
  32. 32.
    Berk AJ (1986) Adenovirus promoters and El A transactivation. Annu Rev Genet 20:45–79PubMedCrossRefGoogle Scholar
  33. 33.
    Manfredi JJ, Prives C (1994) The transforming activity of simian virus 40 large tumor antigen. Biochim Biophys Acta 1198:65–83PubMedGoogle Scholar
  34. 34.
    Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck A, Stremlau B, zur Hausen H (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114PubMedCrossRefGoogle Scholar
  35. 35.
    Sakamuro D, Furukawa T, Takegami T (1995) Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 69:3893–3896PubMedGoogle Scholar
  36. 36.
    Kato N, Shiratori Y, Omata M (1996) Hepatitis C virus genotypes: molecular basis and clinical significance. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol. XIV. Saunders, Philadelphia, pp 223–244Google Scholar
  37. 37.
    Kato N, Hijikata M, Ootsuyama Y, Nakagawa N, Ohkoshi S, Sugimura T, Shimotohno K (1990) Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87:9524–9528PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1999

Authors and Affiliations

  • Naoya Kato
    • 1
  • Keng-Hsin Lan
    • 1
  • Suzane Kioko Ono-Nita
    • 1
  • Hideo Yoshida
    • 1
  • Yasushi Shiratori
    • 1
  • Masao Omata
    • 1
  1. 1.Second Department of Internal Medicine, Faculty of MedicineUniversity of TokyoBunkyo-ku, TokyoJapan

Personalised recommendations